IVF Devices and Consumables Market by Product (Instrument, Accessory & Disposable, and Reagent & Media), Technology (Fresh Embryo IVF, Frozen Embryo IVF, and Donor Egg IVF), and End User (Fertility Clinic, Hospital, Surgical Center, and Clinical Research Institute): Global Opportunity Analysis and Industry Forecast, 2021 – 2027

ID: VPR/HC/222 Publishing Year: February 2021 Pages: 168 Format:   


The Global IVF Devices And Consumables Market size was valued at $XX million in 2019, and is projected to reach $XX million by 2027, growing at a CAGR of XX% from 2021 to 2027.

In vitro fertilization is the process of fertilization where an egg is combined with sperm outside of body that is in vitro which means the glass. IVF is a type of assisted reproductive technology used for infertility treatment and gestational surrogacy. After the IVF treatment, some couples get pregnant without any fertility treatments. Today, the scientific term "in vitro" is used to refer to any biological procedure that is performed outside the organism in which it would normally have occurred.

IVF technology helps couple who cannot conceive naturally, ultimately resulting in pergrancy and healthy baby. However, couples with health problems such as PCOD, male infertility, premature ovarian failure problem will have a much higher chance of conceiving through IVF technology which will drive the growth of market. For single women or same-sex couples who wish to have a child, IVF can provide a great opportunity for helping them to become parents. However, the side effects of IVF such as multiple pregnancies, IVF unsuccessful ,expensive treatment may hamper the growth of market. Conversely, rise of fertility tourism, especially in emerging markets, increase in number of fertility clinics, and rise in same sex marriages are anticipated to provide lucrative growth opportunities to the market players in the IVF Devices and Consumables Market.

Segmentation of Global IVF Devices And Consumables:

The Global IVF Devices And Consumables Market is segmented into product, technology ,end user and region. Based on product it is further divided into Instrument, Accessory & Disposable, and Reagent & Media . Technology is segmented into Fresh Embryo IVF, Frozen Embryo IVF, and Donor Egg IVF. By end user Fertility Clinic, Hospital, Surgical Center, and Clinical Research Institute. Region wise it is observed across north America, Europe ,asia-pacific and LAMEA.

By Product Insight:

At present, the accessory & disposable segment is the major revenue contributor, and is expected to dominate the market during the forecast period, owing to its vital role in every IVF procedure, such as retrieval of oocytes, analysis & screening of sperms, handling gametes, and others. However, the instrument segment is anticipated to grow at the highest rate, due to technological advancements and increase in demand for advanced IVF Devices.

By Technology Insight

The fresh embryo IVF segment is the major revenue contributor, and is expected to show dominance during the forecast period, due to its advantages such as higher success rate, convenience, cost-effectiveness, and enhanced safety. Furthermore, delayed pregnancy trends in women, advantages of fresh embryo transfer over the frozen embryo technique, and higher success rate of this technique majorly drive the growth of the fresh embryo IVF segment in the IVF Devices And Consumables Market.

By Region Insight

Asia-Pacific presents lucrative opportunities for the key players operating in the IVF Devices And Consumables Industry, owing to growth in awareness about IVF treatment, rise in number of infertile population, increase in fertility tourism, and surge in disposable income.

The key players profiled in the IVF devices and consumables market report include Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (Cooper Surgical, Inc.), Thermo Fisher Scientific, Inc., and Vitro life AB

IVF Devices and Consumables Key Market Segments:

By Product

  • Instrument
    • Sperm Separation System
    • Cryosystem
    • Incubator
    • Imaging System
    • Ovum Aspiration Pump
    • Cabinet
    • Micromanipulator
    • Others
  • Accessory & Disposable
  • Reagent & Media
    • Cryopreservation Media
    • Semen Processing Media
    • Ovum Processing Media
    • Embryo Culture Media

By Technology Type

  • Fresh Embryo IVF
  • Frozen Embryo IVF
  • Donor Egg IVF

By End User

  • Fertility Clinic
  • Hospital
  • Surgical Center
  • Clinical Research Institute

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

TABLE OF CONTENTS:

CHAPTER 1 MARKET INTRODUCTION

1.1. REPORT OVERVIEW

1.2. SCOPE OF THE STUDY

1.3. PRIMARY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

2.1. C-LEVEL EXECUTIVE’S OVERVIEW AND PERSPECTIVES

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. PRINCIPAL FINDINGS

3.2.1. Key investment pockets

3.2.2. Leading winning strategies

  3.2.3 Key Player Positioning

3.3. PORTERS FIVE FORCES OF COMPETITIVE ANALYSIS

 3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Impact Analysis

3.5. IMPACT OF COVID-19 ON THIS MARKET

CHAPTER 4 .GLOBAL IVF DEVICES AND CONSUMABLES MARKET , BY PRODUCT TYPE

4.1. SYNOPSIS

4.1.1. Market size and forecast

4.2. INSTRUMENT

4.2.1. Key market trends

4.2.2. Growth factors and opportunities

4.2.3. Market size and forecast

4.3. ACCESSORY AND DISPOSABLE

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

4.3.3. Market size and forecast

  4.4 REAGENT AND MEDIA

4.4.1. Key market trends

4.4.2. Growth factors and opportunities

4.4.3. Market size and forecast  

CHAPTER 5 GLOBAL IVF DEVICES AND CONSUMABLES MARKET ,BY TECHNOLOGY

  5.1 SYNOPSIS

5.1.1. Market size and forecast

  5.2 HFRESH EMBRYO IVF

5.2.1. Key market trends

5.2.2. Growth factors and opportunities

5.2.3. Market size and forecast

  5.3 FROZEN EMBRYO IVF

5.3.1. Key market trends

5.3.2. Growth factors and opportunities

5.3.3. Market size and forecast

  5.4 DONAR EMBRYO IVF

5.4.1. Key market trends

5.4.2. Growth factors and opportunities

5.4.3. Market size and forecast

 CHAPTER 6 GLOBAL IVF DEVICES AND CONSUMABLES MARKET,BY END USER

  6.1 SYNOPSIS

6.2 FERTILITY CLINIC

6.2.1. Key market trends

6.2.2. Growth factors and opportunities

6.2.3. Market size and forecast

6.3 HOSPITALS

6.3.1. Key market trends

6.3.2. Growth factors and opportunities

6.3.3. Market size and forecast

6.4 SURGICALCENTER

6.4.1. Key market trends

6.4.2. Growth factors and opportunities

6.4.3. Market size and forecast

6.5 CLINIC RESEARCH CENTER

   6.5.1. Key market trends

6.5.2. Growth factors and opportunities

  6.5.3. Market size and forecast 

CHAPTER 7 GLOBAL IVF DEVICES AND CONSUMABLES MARKET , BY REGION

7.1 SYNOPSIS

7.2 North America

7.2.1 Key market trends

7.2.2 Competitive scenario

7.2.3 Key growth factors and opportunities

7.2.4 Market size and forecast

  7.3 Europe

7.3.1 Key market trends

7.3.2 Competitive scenario

7.3.3 Key growth factors and opportunities

7.3.4 Market size and forecast

7.4 Asia Pacific

7.4.1 Key market trends

7.4.2 Competitive scenario

7.4.3 Key growth factors and opportunities

7.4.4 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends

7.5.2 Key growth factors and opportunities

7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

  8.1 Cook Medical Inc

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Product portfolio

8.1.4. Business performance

8.1.5. Key strategic moves and developments

8.2. Fujifilm Holdings Corporation (Irvine Scientific Sales Company

8.2.1. Company overview

8.2.2. Company snapshot

  8.2.4. Product portfolio

8.2.5. Business performance

8.2.5. Key strategic moves and developments

8.3. Genea Biomedx

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.3.5. Business performance

8.3.5. Key strategic moves and developments

8.4. Merck KGaA (EMD Serono, Inc.)

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.5. Key strategic moves and developments

8.5. Millendo Therapeutics, Inc

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Business performance

8.5.5. Key strategic moves and developments

8.6. Oxford Gene Technology

8.6.1. Company overview

8.6.2. Company Snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

8.6.6Key strategic moves and developments

8.7. Progyny Inc

 8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

8.7.5. Key strategic moves and developments

8.8. The Cooper Companies, Inc. (Cooper Surgical, Inc.)

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Business performance

8.8.5. Key strategic moves and developments

8.9. Thermo Fisher Scientific

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.5. Key strategic moves and developments

8.10 Vitro life AB

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Product portfolio

8.10.4. Key strategic moves and developments


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]